Westwood Wealth Management decreased its position in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) by 42.9% during the 4th quarter, Holdings Channel.com reports. The fund owned 8,000 shares of the exchange traded fund’s stock after selling 6,000 shares during the period. Westwood Wealth Management’s holdings in ProShares Ultra Nasdaq Biotechnology were worth $405,000 at the end of the most recent reporting period.
Separately, Jane Street Group LLC boosted its position in ProShares Ultra Nasdaq Biotechnology by 8.4% during the third quarter. Jane Street Group LLC now owns 4,803 shares of the exchange traded fund’s stock worth $306,000 after purchasing an additional 374 shares in the last quarter.
ProShares Ultra Nasdaq Biotechnology Stock Down 11.2 %
Shares of BIB stock opened at $40.45 on Friday. The stock has a market cap of $44.90 million, a P/E ratio of 19.79 and a beta of 1.49. ProShares Ultra Nasdaq Biotechnology has a fifty-two week low of $40.37 and a fifty-two week high of $69.56. The business has a fifty day simple moving average of $53.44 and a 200-day simple moving average of $56.57.
ProShares Ultra Nasdaq Biotechnology Cuts Dividend
ProShares Ultra Nasdaq Biotechnology Profile
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
Recommended Stories
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- How to Use Stock Screeners to Find Stocks
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How to Calculate Stock Profit
- Spotify Stock Eyes Double-Digit UpsideāIs Now the Time to Buy?
Want to see what other hedge funds are holding BIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report).
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.